AcouSort AB

AcouSort AB

ACOU · ST · Healthcare / Biotechnology

2.70SEK+0.36 (+15.38%)

Price History

Full chart

Market Stats

Previous Close2.34
Open2.72
Day Range2.25 – 2.88
52-Week Range2.03 – 5.16
Volume154.21K
Market Cap75.77M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.51
Dividend Yield0.00%
Beta0.09
50-Day Avg3.09
200-Day Avg3.29

About

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has a collaboration agreement with Moeller Medical to exhibit a prototype system for analyzing separation of cells from body fluids. AcouSort AB (publ) was incorporated in 2010 and is based in Lund, Sweden.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Torsten Freltoft M.Sc., Ph.D.
  • Employees11
  • HeadquartersBuilding 406, Lund, Sweden, 223 81, Sweden
  • Websitehttps://www.acousort.com

Leadership

  • Mr. Torsten Freltoft M.Sc., Ph.D.Chief Executive Officer · b. 1958
  • Prof. Thomas Laurell Ph.D.Founder & Independent Director · b. 1961
  • Dr. Stefan Scheding M.D.Founder & Independent Director · b. 1962
  • Prof. Patrik Brundin M.D., Ph.D.Founder
  • Dr. Hans LiljaFounder
  • Mr. Gunnar TelhammarChief Financial Officer · b. 1961

Financials

Income Statement

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue832.55K1.95M1.58M2.72M2.48M1.07M1.86M4.93M3.01M4.96M10.55M4.74M6.85M
Growth (%)-+133.87%-19.09%+72.79%-8.82%-56.73%+72.81%+165.52%-38.98%+65.05%+112.59%-55.10%+44.67%
Cost of Revenue1.76M1.91M1.87M3.37M532.00K957.00K777.00K1.89M2.46M2.05M2.16M-34.00K21.36M
Gross Profit-929.45K35.12K-294.65K2.72M1.95M117.00K1.08M3.04M548.00K2.91M8.39M4.77M-14.50M
Gross Margin-111.64%1.80%-18.70%100.00%78.57%10.89%58.14%61.59%18.22%58.65%79.51%100.72%-211.62%
Operating Expense-743.64K-100.71K3003.37M8.02M9.09M10.72M10.85M12.70M17.26M25.88M20.90M0
Operating Income-185.81K135.82K-294.95K-643.00K-6.07M-8.97M-9.65M-7.81M-12.15M-14.35M-17.49M-16.13M-14.50M
Operating Margin-22.32%6.98%-18.72%-23.62%-244.64%-835.29%-519.72%-158.56%-404.19%-289.12%-165.74%-340.43%-211.62%
EBITDA-62.15K140.46K-279.00K-643.00K-6.06M-8.91M-9.59M-7.64M-11.46M-12.86M-16.70M-15.89M-14.33M
EBITDA Margin-7.46%7.21%-17.71%-23.62%-244.00%-829.98%-516.43%-154.99%-380.94%-259.10%-158.31%-335.49%-209.06%
Net Income-62.72K108.01K-278.85K-830.00K-6.07M-8.96M-9.68M-8.22M-12.38M-13.21M-17.09M-15.08M-12.15M
Net Income Margin-7.53%5.55%-17.70%-30.49%-244.64%-834.26%-521.71%-166.80%-411.74%-266.19%-161.97%-318.30%-177.34%
Interest Expense384614.00K187.00K0026.00K242.00K181.00K15.00K2.00K729.00K1.34M
Interest Expense % of Total Revenue0.00%0.02%0.25%6.87%0.00%0.00%1.40%4.91%6.02%0.30%0.02%15.39%19.50%

Balance Sheet

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.41M920.08K260.70K12.04M4.95M17.44M8.04M13.17M36.56M42.66M34.51M12.32M17.89M
Total Liabilities2.16M543.60K182.07K2.08M1.06M1.86M2.11M3.58M3.54M22.54M10.38M3.86M1.59M
Total Equity249.47K376.48K78.63K9.96M3.88M15.58M5.92M9.59M33.02M20.11M24.14M8.46M16.30M
Cash2.11M852.20K95.15K461.00K2.44M15.53M5.10M8.12M31.52M33.97M23.99M3.57M6.29M
Total Debt1.89M195.70K-----------
Net Debt-222.43K-656.50K-95.15K-461.00K-2.44M-15.53M-5.10M-8.12M-31.52M-33.97M-23.99M-3.57M-6.29M

Cash Flow

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.01M-8.60M-757.00K-214.00K-8.53M-7.40M-9.84M-7.04M-10.92M3.96M-31.56M-18.81M-16.78M
Investing Cash Flow-640.00K-417.00K---494.00K-168.00K-587.00K-1.59M-1.31M-1.01M-1.16M-1.02M-488.00K
Financing Cash Flow6.01M7.47M-580.00K11.00M20.66M11.65M11.65M35.63M191.00K22.08M-157.00K18.98M
Capital Expenditure0000494.00K159.00K587.00K1.59M1.31M1.01M213.00K1.03M16.78M
Free Cash Flow-3.01M-8.60M-757.00K-214.00K-9.02M-7.56M-10.43M-8.63M-12.23M2.95M-31.77M-19.84M-17.27M
FCF to OCF100.00%100.00%100.00%100.00%105.79%102.15%105.96%122.64%112.04%74.50%100.67%105.47%102.91%

Earnings

Report DateDec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Apr 24, 2024Aug 30, 2024Nov 27, 2024Feb 14, 2025May 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------
EPS Actual-0.29-0.14-0.30-0.30-0.27-0.20-0.30-0.32-0.22-0.23-0.24-0.32-0.49-0.25-0.32-0.25-0.19-0.27-0.14-0.13-0.14-0.11-0.17
Surprise-----------------------
Timing-------------Pre-marketPre-marketPre-marketPre-marketPre-market-----

Key Statistics & Ratios

Market Cap75.77M
Enterprise Value53.59M
Trailing P/E0.00
Forward P/E0.00
Price / Sales8.13
Price / Book6.43
EPS-0.51
Book Value0.463
Revenue (TTM)9.31M
Gross Profit (TTM)9.06M
EBITDA-11.64M
Profit Margin-120.49%
Operating Margin-168.67%
Return on Equity-72.25%
Return on Assets-30.77%
Shares Outstanding21.16M
Shares Float15.77M
Beta0.09
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Nov 13, 2023234:233
  • Sep 24, 2021917:891